What is the recommended colchicine dosing for an acute gout flare in adults, including adjustments for elderly patients, renal or hepatic impairment, and concomitant strong CYP3A4 or P‑glycoprotein inhibitors?

Colchicine Dosing for Acute Gout

For an acute gout flare, administer colchicine 1.2 mg (two tablets) immediately at flare onset, followed by 0.6 mg (one tablet) exactly one hour later, for a maximum total of 1.8 mg within the first hour. 1, 2, 3

Timing Is Critical

• Start treatment within 12 hours of symptom onset for optimal pain relief; effectiveness declines markedly after 36 hours. 2, 4
• If the flare began more than 36 hours ago, do not use colchicine—select an NSAID or corticosteroid instead. 1
• After completing the acute doses, wait 12 hours before resuming prophylactic colchicine (if applicable). 1

Evidence Base for Low-Dose Regimen

• The low-dose regimen (1.8 mg total over 1 hour) achieves 37.8% response rate (≥50% pain reduction at 24 hours) versus 15.5% with placebo, with a safety profile indistinguishable from placebo. 4
• High-dose regimens (4.8 mg over 6 hours) provide no additional efficacy but cause severe gastrointestinal toxicity in 76.9% of patients (diarrhea) and should never be used. 1, 2, 4

Absolute Contraindications

Do not prescribe colchicine if any of the following apply:

• Strong CYP3A4 or P-glycoprotein inhibitors (clarithromycin, erythromycin, ketoconazole, ritonavir, cyclosporine, telithromycin) are being taken—fatal toxicity has been reported with these combinations, especially in patients with any degree of renal or hepatic impairment. 1, 2, 3
• Severe renal impairment (creatinine clearance <30 mL/min or dialysis)—use corticosteroids instead. 1, 2, 3
• Patient is already taking prophylactic colchicine—if a flare occurs during prophylaxis, choose an NSAID or corticosteroid for acute treatment, not additional colchicine. 1, 2

Renal Impairment Adjustments

Mild Renal Impairment (CrCl 60–89 mL/min)

• No dose adjustment required; use standard 1.2 mg then 0.6 mg regimen. 3, 5
• Monitor closely for adverse effects. 3

Moderate Renal Impairment (CrCl 30–50 mL/min)

• Reduce to 0.6 mg once, followed by 0.3 mg one hour later. 1, 3
• Do not repeat the dose for at least 3 days (not 2 weeks as with severe impairment). 1
• Monitor closely for adverse effects. 3

Severe Renal Impairment (CrCl <30 mL/min)

• Colchicine is contraindicated for acute gout; use corticosteroids instead. 1, 2
• If absolutely necessary, maximum single dose of 0.6 mg, not to be repeated more than once every 2 weeks. 3

Dialysis Patients

• Maximum single dose of 0.6 mg for acute treatment, not to be repeated more than once every 2 weeks. 3
• Corticosteroids are strongly preferred. 1

Hepatic Impairment Adjustments

Mild to Moderate Hepatic Impairment

• No dose adjustment required for acute treatment. 3
• Monitor closely for adverse effects. 3

Severe Hepatic Impairment

• Consider dose reduction, though specific recommendations are not established. 3
• Avoid colchicine entirely if patient is also taking CYP3A4/P-gp inhibitors. 3

Drug Interaction Management

Strong CYP3A4/P-gp Inhibitors (CONTRAINDICATED)

Absolute contraindication—do not use colchicine with: 1, 2, 3

• Clarithromycin, erythromycin, telithromycin
• Ketoconazole, itraconazole
• Ritonavir, atazanavir, darunavir, indinavir, lopinavir, nelfinavir, saquinavir, tipranavir
• Cyclosporine
• Nefazodone

Moderate CYP3A4 Inhibitors (Dose Reduction Required)

If unavoidable, reduce to 1.2 mg once (do not give second 0.6 mg dose), and do not repeat for at least 3 days: 1, 3

• Diltiazem, verapamil
• Fluconazole
• Grapefruit juice
• Aprepitant

P-gp Inhibitors (Dose Reduction Required)

Reduce to 0.6 mg once (do not give second dose), and do not repeat for at least 3 days: 1, 3

• Ranolazine

Elderly Patient Considerations

• Age-related decline in renal function is common; calculate creatinine clearance using Cockcroft-Gault formula and adjust dose accordingly. 6
• Start with lower doses if renal function is borderline (CrCl 30–60 mL/min). 6
• Elderly patients on statins require close monitoring for neuromuscular toxicity (myopathy, rhabdomyolysis). 2, 7
• High cost and gastrointestinal intolerance may limit use; corticosteroids may be preferred. 6

Alternative First-Line Therapies

The American College of Physicians strongly recommends corticosteroids as first-line therapy for acute gout due to superior safety profile: 1

• Prednisolone 35 mg once daily for 5 days (no taper needed) provides equivalent pain relief to NSAIDs with fewer adverse events. 1
• Preferred in patients with chronic kidney disease, heart failure, cirrhosis, or GI bleeding history. 1
• NSAIDs (naproxen 500 mg twice daily or indomethacin 50 mg three times daily) are acceptable alternatives if corticosteroids are contraindicated. 1

Common Pitfalls to Avoid

• Never use high-dose hourly colchicine regimens—they are obsolete and cause dangerous toxicity without added benefit. 1, 2
• Do not reflexively choose colchicine over corticosteroids—guidelines prioritize corticosteroids for safety. 1
• Do not add acute colchicine dosing if patient is already on prophylactic colchicine—switch to NSAID or corticosteroid instead. 1, 2
• Do not overlook drug interactions—fatal toxicity occurs with CYP3A4/P-gp inhibitors, particularly in patients with renal impairment. 1, 2, 7, 8
• Do not assume "no dose adjustment" means "no monitoring"—even with mild renal impairment, close surveillance is required. 3

Monitoring for Toxicity

• Watch for myelosuppression (pancytopenia, leukopenia, neutropenia, thrombocytopenia), especially in patients with renal impairment or taking CYP3A4/P-gp inhibitors. 7
• Monitor for neuromuscular toxicity (myopathy, rhabdomyolysis), particularly in elderly patients on statins. 2, 7
• Most common adverse effects at recommended doses: diarrhea (23% vs. 77% with high-dose), nausea, vomiting. 4